Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
4.300
-0.160 (-3.59%)
At close: Mar 31, 2025, 4:00 PM
4.454
+0.154 (3.59%)
After-hours: Mar 31, 2025, 7:29 PM EDT
Jasper Therapeutics Stock Forecast
JSPR's stock price has decreased by -85.35% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 62.5, with a low estimate of 38 and a high estimate of 90. The average target predicts an increase of 1,353.49% from the current stock price of 4.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Jasper Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 7 | 7 | 8 | 8 | 8 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +830.23% | Mar 11, 2025 |
| UBS | UBS | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +783.72% | Feb 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $70 | Buy | Reiterates | $70 | +1,527.91% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +830.23% | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $68 → $48 | Buy | Maintains | $68 → $48 | +1,016.28% | Jan 9, 2025 |
Financial Forecast
Revenue This Year
n/a
from 130.71M
Revenue Next Year
n/a
EPS This Year
-4.60
from -4.89
EPS Next Year
-5.11
from -4.60
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 46.2M | 10.5M | 24.1M | ||
| Avg | 4.5M | 1.4M | 5.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -64.7% | 134.0% | 1,563.2% | ||
| Avg | -96.6% | -67.7% | 277.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.63 | -3.78 | -7.30 | ||
| Avg | -4.60 | -5.11 | -7.69 | ||
| Low | -6.69 | -8.01 | -7.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.